Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Intra-Cellular Therapies, Inc. (ITCI) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/07/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
07/07/2023 4/A Halstead Michael (EVP and General Counsel) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Granted 40,472 options to buy @ $53.63, valued at $2.2M
07/07/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/19/2019 4/A Alafi Christopher D (Director) has filed a Form 4 on Intra-Cellular Therapies, Inc.
Txns: Bought 10,000 shares @ $15.55, valued at $155.5k
01/03/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
01/03/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
01/03/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
01/03/2018 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/20/2016 4/A Form 4 - Statement of changes in beneficial ownership of securities [amend]
04/04/2016 4/A Hineline Lawrence J. (VP of Finance CFO) has filed a Form 4 on Intra-Cellular Therapies, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy